This inventor holds 1 USPTO granted patent and 11 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jibo Wang: Innovator in RNA Interference Technology
Introduction
Jibo Wang is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of RNA interference agents. His work focuses on innovative solutions for treating tauopathies, which are neurodegenerative diseases associated with tau protein abnormalities.
Latest Patents
Jibo Wang holds a patent for MAPT RNA interference agents. This patent, which includes 1 patent, provides methods and compositions for reducing MAPT expression and treating tauopathy in subjects. The invention represents a promising advancement in therapeutic strategies for neurodegenerative conditions.
Career Highlights
Wang is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development in the area of RNA interference, where he applies his expertise to create innovative treatments for complex diseases.
Collaborations
Jibo Wang collaborates with talented colleagues, including Jeremy Schulenburg York and Sarah Katharina Fritschi. Their combined efforts contribute to the advancement of research and development in the field of biotechnology.
Conclusion
Jibo Wang's contributions to RNA interference technology highlight his role as an influential inventor in the biotechnology sector. His innovative work continues to pave the way for new therapeutic approaches to treat neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile